NCT06431191

Brief Summary

This study is a prospective randomized controlled study of rotator cuff repair with lateral raw or double raw combined with microfracture procedure. The patients with rotator cuff tear were randomly divided into groups before the operation. The patients were followed up before and, 3 months, 6 months, 12 months and 24 months after surgery. In different time periods, the quantitative and qualitative indicators including pain, functional score, muscle strength, MRI performance, etc. were compared between groups at the same time period to evaluate the difference in the effect of double raw or only lateral raw repair combined with microfracture on the treatment of rotator cuff. In order to figure out whether medial raw anchor necessary during tendon repair combined with microfracture in small to medium size rotator cuff tear.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jan 2023Dec 2026

Study Start

First participant enrolled

January 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2023

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

May 28, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

4 years

First QC Date

March 18, 2023

Last Update Submit

May 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • rotator cuff re-tear rate

    the rotator cuff re-tear rate was measured by MRI, MRI was performed to identify the status of the tendon

    6, 12, 24 months postoperatively

Secondary Outcomes (8)

  • VAS (Visual Analogue Scale)

    1,2,3,7 days postoperatively and 3,6,12,24 months postoperatively

  • ASES(American Shoulder and Elbow Surgeons'Form)

    3,6,12,24 months postoperatively

  • Constant score

    3,6,12,24 months postoperatively

  • UCLA (University LosAngeles scoring system)

    3,6,12,24 months postoperatively

  • SST (simple shoulder test)

    3,6,12,24 months postoperatively

  • +3 more secondary outcomes

Study Arms (2)

Study group

EXPERIMENTAL

lateral raw repair for full tear rotator cuff combined microfracture procedure

Procedure: lateral raw

Control group

PLACEBO COMPARATOR

double raw repair for full tear rotator cuff combined microfracture procedure

Procedure: double raw

Interventions

lateral rawPROCEDURE

lateral raw repair for full tear rotator cuff combined microfracture procedure, without medial raw

Study group
double rawPROCEDURE

double raw repair for full tear rotator cuff combined microfracture procedure

Control group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Arthroscopy confirmed small to medium full rotator cuff tear
  • Unilateral rotator cuff injury
  • Voluntarily accept randomized controlled grouping, cooperate with treatment and follow up patients
  • Young and middle-aged patients aged 20 to 60

You may not qualify if:

  • Previous shoulder surgery (incision or arthroscopy)
  • Combined with diseases of other parts of the same limb
  • Combined with Bankart injury, acromioclavicular joint disease, greater tuberosity fracture, glenoid fracture and so on
  • Bilateral onset
  • Unable or unwilling to receive clinical follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Jishuitan hospital

Beijing, Beijing Municipality, 100000, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Sports Medicine Service of Beijing Jishuitan hospital

Study Record Dates

First Submitted

March 18, 2023

First Posted

May 28, 2024

Study Start

January 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations